人源化免疫肺癌小鼠模型的建立及其在程序性死亡受体1抑制剂疗效评估中的作用
周 箴1,徐云华1,张菲菲2,赵 艺1,郭 林2,付国龙2,沈盛萍1,冷雪娇1
Establishment of a lung cancer momodel with humanized immunity and its role in efficacy evaluation of programmed death-1 inhibitors
ZHOU Zhen, XU Yun-hua, ZHANG Fei-fei, ZHAO Yi, GUO Lin, FU Guo-long, SHEN Sheng-ping, LENG Xue-jiao
上海交通大学学报(医学版) . 2020, (1): 37 .  DOI: 10.3969/j.issn.1674-8115.2020.01.006